Cargando…
A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells
INTRODUCTION: Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. However, this degradation is not a sustained and efficient process. Therefore, we designed a cyclic pepti...
Autores principales: | Shi, Yu-Ying, Dong, Di-Rong, Fan, Gang, Dai, Meng-Yuan, Liu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577221/ https://www.ncbi.nlm.nih.gov/pubmed/37849747 http://dx.doi.org/10.3389/fimmu.2023.1237964 |
Ejemplares similares
-
Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells
por: Shi, Yu-Ying, et al.
Publicado: (2023) -
High-potency PD-1/PD-L1 degradation induced by Peptide-PROTAC in human cancer cells
por: Dai, Meng-Yuan, et al.
Publicado: (2022) -
Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression
por: Wang, Kun, et al.
Publicado: (2022) -
Specific MHC-I Peptides Are Induced Using PROTACs
por: Jensen, Stephanie M., et al.
Publicado: (2018) -
Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs
por: Qin, Qiaohua, et al.
Publicado: (2022)